Translation, cross-cultural adaptation, and validation of the Greek version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19
Creators: name: Nikolaidis, Ioannis
name: Karakasi, Maria–Valeria
name: Artemiadis, Artemios
name: Nteli, Elli
name: Bakirtzis, Christos
name: Boziki, Marina–Kleopatra
name: Foley, Frederick W.
name: Grigoriadis, Nikolaos
Publisher: name: Taylor & Francis
Year: 2022
Subjects: subject: Space Science
subject: Medicine
subject: Environmental Sciences not elsewhere classified
subject: Sociology
subject: FOS: Sociology
subject: Biological Sciences not elsewhere classified
subject: Science Policy

description: Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19) explores optimally impact of MS on sexual activity/satisfaction/intimacy. The present study aims to provide the only validation of the Greek Version of MSISQ-19, and compare results to validation studies in other languages. The original/English version of the MSISQ-19 was translated into Greek according to standardized guidelines, while validity/reliability, correlations with other scales and sexual dysfunction prevalence were tested. Subjects were requested to complete all questionnaires and MSISQ-19, being re-tested three weeks later. Construct-validity of the Greek version of the MSISQ-19 was confirmed with principal-component-analysis. Bartlett’s test assessed correlation-adequacy between items. Pearson’s correlation explored internal-construct-validity between subscales and overall score, and external–construct-validity with disease-status variables, cognitive testing and patient-reported outcomes regarding fatigue, depression/anxiety, MS impact, and quality of life. 201 PwMS (130 female). Mean age was 39.3 ± 11.8 years with median disease-duration 11.7 ± 7.9 years. 79.1% RRMS, PPMS (10.4%) and SPMS (10.4%). Cronbach’s alpha coefficient was 0.949. MSISQ-19 correlations between items were large. Significant associations of sexual dysfunction were identified with age (rho = 0.392, <i>p</i> &lt; 0.01), years of education (rho=–0.199, <i>p</i> = 0.006), the Expanded Disability Status Scale (rho = 0.518, <i>p</i> &lt; 0.01) and MS duration (rho = 0.354, <i>p</i> &lt; 0.01). Correlations were disclosed with the Brief International Cognitive Assessment for MS (rho=-0.247, <i>p</i> &lt; 0.05), Modified Fatigue Impact Scale (rho = 0.374, <i>p</i> &lt; 0.05), Depression Anxiety Stress Scale (rho = 0.375, <i>p</i> &lt; 0.05), Multiple Sclerosis Impact Scale (rho = 0.442, <i>p</i> &lt; 0.05), and EuroQoL-five-dimensional instrument (rho = 0.375, <i>p</i> &lt; 0.05). Internal consistency of the Greek version of the MSISQ-19 was confirmed with Cronbach’s alpha. Test-retest reliability (31 PwMS) was excellent with intraclass-correlation-coefficients &gt; 0.90. Besides Greek MSISQ-19 satisfactory validity/reliability/reproducibility and being first to include cognitive-testing, authors estimated sexual-dysfunction prevalence affecting half PwMS.HIGHLIGHTSThis study provides the only validation of the Greek Version of the MSISQ-19.The latter was found with satisfactory validity, reliability and reproducibility.50% of the Greek PwMS sample was found to be afflicted with sexual dysfunction.This is also the first validation study to examine associations with cognitive testing.Sexual function is still an underestimated functionality parameter upon examination. This study provides the only validation of the Greek Version of the MSISQ-19. The latter was found with satisfactory validity, reliability and reproducibility. 50% of the Greek PwMS sample was found to be afflicted with sexual dysfunction. This is also the first validation study to examine associations with cognitive testing. Sexual function is still an underestimated functionality parameter upon examination.